New data links Covid-19’s origins to raccoon dogs at Wuhan market

Analysis of gene sequences by international team finds Covid-positive samples rich in raccoon dog DNA

Newly released genetic data gathered from a live food market in Wuhan has linked Covid-19 with raccoon dogs, adding weight to the theory that infected animals sold at the site started the coronavirus pandemic, researchers involved in the work say.

Swabs collected from stalls at the Huanan seafood market in the two months after it was shut down on 1 January 2020 were previously found to contain both Covid and human DNA. When the findings were published last year, Chinese researchers stated that the samples contained no animal DNA.

Continue reading...
New data links Covid-19’s origins to raccoon dogs at Wuhan market

Analysis of gene sequences by international team finds Covid-positive samples rich in raccoon dog DNA

Newly released genetic data gathered from a live food market in Wuhan has linked Covid-19 with raccoon dogs, adding weight to the theory that infected animals sold at the site started the coronavirus pandemic, researchers involved in the work say.

Swabs collected from stalls at the Huanan seafood market in the two months after it was shut down on 1 January 2020 were previously found to contain both Covid and human DNA. When the findings were published last year, Chinese researchers stated that the samples contained no animal DNA.

Continue reading...
Prenatal gene test Nifty under international scrutiny amid links to Chinese military

Five countries are assessing the BGI Group test amid regulatory concerns about genetic data being sent abroad

Health regulators in five countries are examining a prenatal test that collects the DNA of women and foetuses for research after it emerged the test’s manufacturer has links to China’s military.

Some doctors and clinics that promoted and sold the test, marketed under the brand name Nifty, said they were unaware that Shenzhen-based BGI Group also conducts research with the Chinese military.

Continue reading...
Reasons to be fearful of China’s data-gathering | Letters

We should be suspicious of the role of the Chinese Communist party in the harvesting of genetic data from unborn babies, argues William Matthews

In her column (What does the Chinese military want with your unborn baby’s genetic data?, 10 July), Arwa Mahdawi suggested that the alleged involvement of the People’s Liberation Army (which is directly answerable to the Chinese Communist party) with BGI’s data-gathering (likewise answerable as a China-based company) is essentially equivalent to data-gathering by western companies. To suggest that the former case is worse, she argued, “smacks of Sinophobia”.

As a scholar of China, I cannot agree. While the harvesting of genetic data by any company is frightening and fraught with ethical issues, it should be obvious that this is a false equivalence. It is undoubtedly worse if genetic data is gathered by a company which must also comply with the rule of the Chinese Communist party (CCP) and its military-industrial complex, a regime which harvests and aggregates data on its citizens on a massive scale and uses it directly to implement the most repressive system of social control on earth in Xinjiang.

Continue reading...
What price a child’s life? India’s quest to make rare disease drugs affordable

Parents whose only hope was finding foreign sponsorship or a clinical trial are now looking for homegrown breakthroughs

For three years, Vidya tried to find the cause of her son’s recurrent fevers and low cognitive development. When she found out, she was devastated.

Vineeth, 10, has an incurable illness – mucopolysaccharidosis type 2 – that affects his organs. Afflicting just one in a million, the enzyme-replacement medication that can help stop the illness getting any worse costs £100,000 a year, far beyond the reach of even a wealthier Indian parent.

Continue reading...
PAGE TOP